Allergic Conjunctivitis
Showing 1 - 25 of 121
Allergic Conjunctivitis Trial in Andover (TL-925, Placebo)
Recruiting
- Allergic Conjunctivitis
- TL-925
- Placebo
-
Andover, MassachusettsAndover Eye Associates
Nov 29, 2023
Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)
Recruiting
- Allergic Conjunctivitis
- MDI-1228_mesylate Ophthalmic Solution
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jul 24, 2023
Allergic Conjunctivitis Trial in Taichung (Vitamin D, Placebo)
Recruiting
- Allergic Conjunctivitis
- Vitamin D
- Placebo
-
Taichung, TaiwanChina Medical University Hospital
May 1, 2023
Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (HPMC-HA eyedrops)
Completed
- Allergic Conjunctivitis
- +2 more
- HPMC-HA eyedrops
-
Catanzaro, CZ, ItalyAzienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 13, 2023
Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (Eye drops for itchy and water eyes)
Completed
- Allergic Conjunctivitis
- +2 more
- Eye drops for itchy and water eyes
-
Catanzaro, CZ, ItalyAzienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 11, 2023
Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%
Not yet recruiting
- Allergic Conjunctivitis
- rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
- Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
- (no location specified)
Apr 4, 2023
Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,
Not yet recruiting
- Allergic Conjunctivitis
- Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
- +3 more
-
Phoenix, Arizona
- +2 more
Nov 9, 2022
Allergic Conjunctivitis Trial in Andover (PRT-2761 0.5%, PRT-2761 1%, Patanol)
Completed
- Allergic Conjunctivitis
- PRT-2761 0.5%
- +4 more
-
Andover, MassachusettsAndover Eye Associates
Oct 13, 2022
Allergic Conjunctivitis, Allergic Rhinitis Trial in Vienna (Eye Drops, Solution in Single-Dose Container)
Completed
- Allergic Conjunctivitis
- Allergic Rhinitis
- Eye Drops, Solution in Single-Dose Container
-
Vienna, AustriaVienna Challenge Chamber
Aug 24, 2022
Allergic Conjunctivitis Trial in Andover (olopatadine HCl ophthalmic solution 0.7%), Fluticasone Propionate, Tears Naturale)
Recruiting
- Allergic Conjunctivitis
- olopatadine hydrochloride ophthalmic solution 0.7%)
- +3 more
-
Andover, MassachusettsAndover Eye Associates
Jul 18, 2022
Allergic Asthma, Allergy to Cats, Allergy to Dust Mites Trial in Iowa City, Boston (Segmental allergen challenge)
Recruiting
- Allergic Asthma
- +4 more
- Segmental allergen challenge
-
Iowa City, Iowa
- +1 more
May 26, 2022
Allergic Conjunctivitis Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)
Recruiting
- Allergic Conjunctivitis
- Reproxalap Ophthalmic Solution (0.25%)
- Vehicle Ophthalmic Solution
-
Mississauga, Ontario, CanadaCliantha Research
May 5, 2022
Allergic Conjunctivitis Trial in Andover (VSJ-110, Placebo)
Completed
- Allergic Conjunctivitis
- VSJ-110
- Placebo
-
Andover, MassachusettsVanda Investigational Site
Apr 26, 2022
Tyrosine Allergoid Paediatric and Adult Study
Recruiting
- Allergic Rhinitis Due to Pollen
- +2 more
- MATA trees or MATA grass
-
Augsburg, GermanyUniversitätsklinikum Augsburg
Jan 10, 2022
Allergic Conjunctivitis Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)
Completed
- Allergic Conjunctivitis
- Reproxalap Ophthalmic Solution (0.25%)
- Vehicle Ophthalmic Solution
-
Mississauga, Ontario, CanadaCliantha Research
Jan 3, 2022
Allergic Conjunctivitis Trial in United States (Bilastine Ophthalmic Solution 0.6%, Ketotifen Ophthalmic Solution 0.025%
Completed
- Allergic Conjunctivitis
- Bilastine Ophthalmic Solution 0.6%
- +2 more
-
Phoenix, Arizona
- +5 more
Nov 16, 2021
Allergic Conjunctivitis Trial in Andover (Bilastine 0.2%, Bilastine 0.4%, Bilastine 0.6%)
Completed
- Allergic Conjunctivitis
- Bilastine 0.2%
- +3 more
-
Andover, MassachusettsOra Clinical Research Center
Oct 28, 2021
Allergic Conjunctivitis Trial in United States (Dexamethasone, 0.4mg, Placebo plug with no drug)
Completed
- Allergic Conjunctivitis
- Dexamethasone, 0.4mg
- Placebo plug with no drug
-
Colorado Springs, Colorado
- +5 more
Sep 9, 2021
Allergic Conjunctivitis Trial in Andover, Memphis (ST266, Saline (0.9% NaCl))
Completed
- Allergic Conjunctivitis
- ST266
- Saline (0.9% NaCl)
-
Andover, Massachusetts
- +1 more
Sep 14, 2021
Proteomic and Metabolomic Lacrimal Fingerprint in Diverse
Recruiting
- Dry Eye Syndrome
- +3 more
- Tear sample collection via Schirmer strip and subsequent analysis by mass spectrometry
-
Montreal, Quebec, Canada
- +1 more
Jul 29, 2021
Allergic Conjunctivitis Trial in Andover (Lifitegrast, Placebo)
Allergic Conjunctivitis Trial in Memphis (EM-100, Zaditor®, Vehicle)
Allergic Rhinitis Due to Tree Pollen, Allergic Conjunctivitis, Allergic Rhinoconjunctivitis Trial in Austin, Grapevine, San
Completed
- Allergic Rhinitis Due to Tree Pollen
- +2 more
- Intra-lymphatic allergenic extract
- Intra-lymphatic placebo
-
Austin, Texas
- +2 more
Mar 29, 2021
Allergic Rhinitis, Allergic Conjunctivitis Trial in Andover (Fluticasone Propionate Nasal Spray, Saline Nasal Spray)
Completed
- Allergic Rhinitis
- Allergic Conjunctivitis
- Fluticasone Propionate Nasal Spray
- Saline Nasal Spray
-
Andover, MassachusettsOra, Inc.
Mar 24, 2021